美国食品药品管理局批准了几十年来首个新的精神分裂症药物, FDA approves first new schizophrenia drug in decades, KarXT, with milder side effects.

美国食品和药物管理局已经批准了KarXT，这是几十年来第一种治疗精神分裂症的新型药物。 The FDA has approved KarXT, the first new type of drug for schizophrenia in decades. 这种药物被认为是有效的,与传统治疗相比,具有较轻的副作用,为病人提供了有希望的替代方法。 This medication is considered effective and has milder side effects compared to traditional treatments, offering a promising alternative for patients. 批准符合FDA早期的预期,标志着在管理这种精神健康状况方面取得了重大进展. The approval aligns with earlier expectations from the FDA, marking a significant advancement in managing this mental health condition. NPR的悉尼卢金报告了这方面的发展。 NPR's Sydney Lupkin reported on this development.